Allsino Pharmaceutical Co., Ltd.

Manufacturer of regulatory starting materials, GMP intermediates and active ingredients, with capabilities in small-molecule organic synthesis, chiral synthesis and solid- and liquid-phase peptide synthesis. It reports over 400 projects across oncology, antivirals, antidepressants, hepatitis and metabolic disease, and a plant with 432 reactors. Founded in 2004. Exports to the United States, Europe and Japan.